Antibodies to myostatin

Details for Australian Patent Application No. 2006239860 (hide)

Owner Amgen Fremont Inc. Pfizer Inc.

Inventors Chin, Eva Rose; Krasney, Philip Albert; Zachwieja, Joseph; Ibebunjo, Chikwendu; Green, Larry; Yie, Junming

Agent Cullens

Pub. Number AU-B-2006239860

PCT Pub. Number WO2006/116269

Priority 60/674,933 25.04.05 US

Filing date 24 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 19 January 2012

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116269 Priority application(s): WO2006/116269

19 January 2012 Application Accepted

  Published as AU-B-2006239860

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239877-Control methods and devices for energy delivery

2006239857-Air inversion and steam cure of cured in place liners apparatus and method